Paid Clinical Trials in Lebanon, NH
As of September 2026, 252 paid clinical trials are recruiting in Lebanon, New Hampshire. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Lebanon offers studies at sites including Dartmouth-Hitchcock Medical Center for conditions such as Acute Myeloid Leukemia, Epilepsy, Breast Cancer, Carcinoma, Non-Small-Cell Lung. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Lebanon
Trials by drug in Lebanon
Filter results
Newly added in Lebanon
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
226 clinical trials
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
A Phase 1/1b Study of IAM1363 in HER2 Cancers
ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II)
Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)
A Study to Assess Growth in Children With Idiopathic Short Stature
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30)
[18F]PI-2620 Phase 3 Histopathological Study
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
Top Research Study Locations in Lebanon
Researchers run research studies in Lebanon, NH at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Dartmouth-Hitchcock Medical Center | Neoplasm Metastasis, Trauma Injury, Cancer | 65 |
| Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center | Acute Myeloid Leukemia, Anatomic Stage II Breast Cancer AJCC v8, B Acute Lymphoblastic Leukemia | 64 |
| Dartmouth Hitchcock Medical Center | Amyotrophic Lateral Sclerosis, Epilepsy, Anesthesia | 56 |
| Dartmouth Hitchcock | ALK Genomic Tumor Aberrations, Advanced Cancer, Advanced Solid Tumor | 9 |
| Dartmouth Cancer Center | Adjuvant Treatment, Advanced Solid Tumor, Advanced Solid Tumors Appropriate for Treatment With Either Nivolumab or Pembrolizumab | 5 |
| Dartmouth Health | Colorectal Adenoma, Colorectal Cancer, Colorectal Neoplasms | 5 |
| Dartmouth-Hitchcock Clinic | Breast Cancer, Fragility Fracture, Infant | 4 |
| Ascendis Investigational Site | Growth Hormone Deficiency | 2 |
| Clinical Study Site | Metastatic Colorectal Cancer (CRC), Non-Small Cell Lung Cancer | 2 |
| Dartmouth College | Anorexia Nervosa, Binge Eating Disorder, Bulimia Nervosa | 2 |
| Dartmouth Hitchcock Medical Center | Carcinoma, Non-Small-Cell Lung | 2 |
| Dartmouth-Health | Spastic Hemiparesis, Spinal Fusion, Spinal Stenosis | 2 |
| Dartmouth-Health Lebanon | Cognitive Dysfunction, Memory Disorders, Memory Dysfunction | 2 |
| Dartmouth-Hitchcock | Cognitive Dysfunction, Cognitive Disorder, Epilepsy, Leukemia | 2 |
| Dartmouth-Hitchcock Clinics | Depression, Major Depressive Disorder, Obesity | 2 |
| Dartmouth-Hitchcock Medical Center-Norris Cotton Cancer Center | Moderately to Severely Active Crohns Disease, Moderately to Severely Active Ulcerative Colitis | 2 |
| Alice Peck Day Memorial Hospital | Suicide Attempt, Suicide Ideation | 1 |
| Children's Hospital at Dartmouth: Geisel School of Medicine | Child, Critical Illness, Hospital Acquired Pressure Ulcer | 1 |
| Cinical Study Site | Chronic Inflammatory Demyelinating Polyneuropathy | 1 |
| Clinical Trial Site | Lichen Planopilaris | 1 |
| Darthmouth-Hitchcock Medical Center | Alzheimer Disease | 1 |
| Dartmouth Cancer Center/Dartmouth-Hitchcock Medical Center | Relapsed/Refractory Locally Advanced or Metastatic Breast Cancer and Triple Negative Breast Cancer | 1 |
| Dartmouth Geisel School of Medicine | Spine Surgery | 1 |
| Dartmouth Hitchcock Cancer Center | Advanced Melanoma | 1 |
| Dartmouth Hitchcock Clinics Heater Road | Pyoderma Gangrenosum | 1 |
Active & Upcoming Studies in Lebanon (2026)
Recruiting trials in Lebanon grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (118 active studies)
- Understanding Information Preferences, Risk Perceptions, and Tradeoffs When Making Decisions About Multi-cancer Early Detection Tests · Trustees of Dartmouth College
- Implementation Intention Planning Guide for FIT Colon Cancer Screening · Dartmouth-Hitchcock Medical Center
Neurology & pain (16 active studies)
- Epileptiform Potential of Fully Immersive Virtual Reality · Dartmouth-Hitchcock Medical Center
- HOBSCOTCH-YOUTH and Young Adults · Dartmouth-Hitchcock Medical Center
Cardiovascular (8 active studies)
- Psychological Trauma, Post-Traumatic Stress Disorder, and Resilience in Adults With Congenital Heart Disease · Dartmouth-Hitchcock Medical Center
- Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention · Phase 4 · Duke University
Mental health & behavior (7 active studies)
- Digitally Enhanced Peer Doula Model for Perinatal Patients With Substance Use Disorder · Trustees of Dartmouth College
- Remote Evaluation and Alerting for Collaborative Health (REACH) in Depression · Dartmouth-Hitchcock Medical Center
Diabetes & metabolic (5 active studies)
- Phentermine's Impact on Treatment in Teens · Phase 2 · Russell McCulloh, MD
- Pilot Trial of the Move Healthier Group · Dartmouth-Hitchcock Medical Center
Pediatric (2 active studies)
- Participatory Approaches to Qualitative Research (PAQ): Comparing Two Approaches to Patient, Public and Clinician Involvement in Qualitative Research · Dartmouth-Hitchcock Medical Center
- Optimizing Tracheal Intubation Outcomes and Neonatal Safety · Children's Hospital of Philadelphia
Common conditions studied in Lebanon
- Acute Myeloid Leukemia (6 active studies)
- Epilepsy (6 active studies)
- Breast Cancer (5 active studies)
- Carcinoma, Non-Small-Cell Lung (5 active studies)
- Ulcerative Colitis (5 active studies)
- Non-Small Cell Lung Cancer (4 active studies)
Leading research sponsors in Lebanon
- Dartmouth-Hitchcock Medical Center
- National Cancer Institute (NCI)
- NRG Oncology
- Children's Oncology Group
- Alliance for Clinical Trials in Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in Lebanon?
There are approximately 252 recruiting clinical trials in Lebanon, New Hampshire listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Lebanon pay participants?
Most recruiting trials in Lebanon compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Lebanon?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Lebanon?
The most common conditions under active study in Lebanon include Acute Myeloid Leukemia (6), Epilepsy (6), Breast Cancer (5), Carcinoma, Non-Small-Cell Lung (5), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Lebanon?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Lebanon on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Lebanon?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Lebanon?
Recruiting research sites in Lebanon include Dartmouth-Hitchcock Medical Center, Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Dartmouth Hitchcock Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Lebanon right now?
The largest active categories in Lebanon are Cancer & tumors (118), Neurology & pain (16), Cardiovascular (8). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.